BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11529317)

  • 1. Multiple pathways of ERK activation by G protein-coupled receptors.
    Gudermann T
    Novartis Found Symp; 2001; 239():68-79; discussion 80-4, 150-9. PubMed ID: 11529317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor-mediated mitogen-activated protein kinase activation through cooperation of Galpha(q) and Galpha(i) signals.
    Blaukat A; Barac A; Cross MJ; Offermanns S; Dikic I
    Mol Cell Biol; 2000 Sep; 20(18):6837-48. PubMed ID: 10958680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of receptor/G protein signaling to cell growth and transformation.
    Gudermann T; Grosse R; Schultz G
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):345-62. PubMed ID: 10763849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins.
    Chan AS; Lai FP; Lo RK; Voyno-Yasenetskaya TA; Stanbridge EJ; Wong YH
    Cell Signal; 2002 Mar; 14(3):249-57. PubMed ID: 11812653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of the insulin-like growth factor-I receptor tyrosine kinase to Gi2 in human intestinal smooth muscle: Gbetagamma -dependent mitogen-activated protein kinase activation and growth.
    Kuemmerle JF; Murthy KS
    J Biol Chem; 2001 Mar; 276(10):7187-94. PubMed ID: 11120746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the ERK/MAPK pathway by an isoform of rap1GAP associated with G alpha(i).
    Mochizuki N; Ohba Y; Kiyokawa E; Kurata T; Murakami T; Ozaki T; Kitabatake A; Nagashima K; Matsuda M
    Nature; 1999 Aug; 400(6747):891-4. PubMed ID: 10476970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells.
    Caverzasio J; Palmer G; Suzuki A; Bonjour JP
    J Bone Miner Res; 2000 Sep; 15(9):1697-706. PubMed ID: 10976990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor isoforms mediate opposing proliferative effects through gbetagamma-activated p38 or Akt pathways.
    Sellers LA; Alderton F; Carruthers AM; Schindler M; Humphrey PP
    Mol Cell Biol; 2000 Aug; 20(16):5974-85. PubMed ID: 10913180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G alpha(i) and G alpha(o) are target proteins of reactive oxygen species.
    Nishida M; Maruyama Y; Tanaka R; Kontani K; Nagao T; Kurose H
    Nature; 2000 Nov; 408(6811):492-5. PubMed ID: 11100733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular signal-regulated kinase 1/2 activation by myometrial oxytocin receptor involves Galpha(q)Gbetagamma and epidermal growth factor receptor tyrosine kinase activation.
    Zhong M; Yang M; Sanborn BM
    Endocrinology; 2003 Jul; 144(7):2947-56. PubMed ID: 12810550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins.
    Wittau N; Grosse R; Kalkbrenner F; Gohla A; Schultz G; Gudermann T
    Oncogene; 2000 Aug; 19(37):4199-209. PubMed ID: 10980593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G2A is an oncogenic G protein-coupled receptor.
    Zohn IE; Klinger M; Karp X; Kirk H; Symons M; Chrzanowska-Wodnicka M; Der CJ; Kay RJ
    Oncogene; 2000 Aug; 19(34):3866-77. PubMed ID: 10951580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable association of G proteins with beta 2AR is independent of the state of receptor activation.
    Lachance M; Ethier N; Wolbring G; Schnetkamp PP; Hébert TE
    Cell Signal; 1999 Jul; 11(7):523-33. PubMed ID: 10405763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of an oncogenic mutant G alpha i2 activates Ras in Rat-1 fibroblast cells.
    Edamatsu H; Kaziro Y; Itoh H
    FEBS Lett; 1998 Nov; 440(1-2):231-4. PubMed ID: 9862461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GIV/Girdin activates Gαi and inhibits Gαs via the same motif.
    Gupta V; Bhandari D; Leyme A; Aznar N; Midde KK; Lo IC; Ear J; Niesman I; López-Sánchez I; Blanco-Canosa JB; von Zastrow M; Garcia-Marcos M; Farquhar MG; Ghosh P
    Proc Natl Acad Sci U S A; 2016 Sep; 113(39):E5721-30. PubMed ID: 27621449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a region at the N-terminus of phospholipase C-beta 3 that interacts with G protein beta gamma subunits.
    Barr AJ; Ali H; Haribabu B; Snyderman R; Smrcka AV
    Biochemistry; 2000 Feb; 39(7):1800-6. PubMed ID: 10677230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cell proliferation by G proteins.
    Dhanasekaran N; Tsim ST; Dermott JM; Onesime D
    Oncogene; 1998 Sep; 17(11 Reviews):1383-94. PubMed ID: 9779986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases.
    Graham TE; Prossnitz ER; Dorin RI
    J Biol Chem; 2002 Mar; 277(13):10876-82. PubMed ID: 11751935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirement of G alpha12, G alpha13, G alphaq, and G beta gamma for endothelin-1-induced c-Jun NH2-terminal kinase and extracellular signal-regulated kinase activation.
    Arai K; Maruyama Y; Nishida M; Tanabe S; Takagahara S; Kozasa T; Mori Y; Nagao T; Kurose H
    Mol Pharmacol; 2003 Mar; 63(3):478-88. PubMed ID: 12606754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming G proteins.
    Radhika V; Dhanasekaran N
    Oncogene; 2001 Mar; 20(13):1607-14. PubMed ID: 11313908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.